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Lysosomal acid lipase (LAL) is essential for the clearance of
endocytosed cholesteryl ester and triglyceride-rich chylomi-
cron remnants. Humans and mice with defective or absent LAL
activity accumulate large amounts of cholesteryl esters and trig-
lycerides in multiple tissues. Although chylomicrons also con-
tain retinyl esters (REs), a role of LAL in the clearance of endo-
cytosed REs has not been reported. In this study, we found that
murine LAL exhibits RE hydrolase activity. Pharmacological
inhibition of LAL in the human hepatocyte cell line HepG2,
incubated with chylomicrons, led to increased accumulation of
REs in endosomal/lysosomal fractions. Furthermore, pharma-
cological inhibition or genetic ablation of LAL in murine liver
largely reduced in vitro acid RE hydrolase activity. Interestingly,
LAL-deficient mice exhibited increased RE content in the duode-
num and jejunum but decreased RE content in the liver. Further-
more, LAL-deficient mice challenged with RE gavage exhibited
largely reduced post-prandial circulating RE content, indicating
that LAL is required for efficient nutritional vitaminA availability.
In summary, our results indicate that LAL is the major acid RE
hydrolase and required for functional retinoid homeostasis.
Lysosomal acid lipase (LAL,2 annotated as LIPA) exhibits
hydrolytic activity at acidic pH and is known to hydrolyze cho-
lesteryl esters (CEs) and triglycerides (TGs) (1, 2). The essential
role of LAL in CE and TG catabolism is evident from the phe-
notype of LAL-deficientmice andhumans (3–5). LAL-deficient
mice exhibit a massive accumulation of CEs and TGs in multi-
ple tissues, most prominently in the liver, spleen, and small
intestine (4). Moreover, the severity of CE and TG accumula-
tion progresses with age, andmice die at the age of 7–8months
(4). Humans carrying mutations in LIPA, which cause partial
or complete inactivationof theprotein, exhibit phenotypesknown
asCEstoragediseaseorWolmandisease, respectively (3, 6).These
patients also show massive accumulation of CEs and TGs in the
liver and small intestine. In contrast to mice, however, complete
inactivation of LAL in humans (patients suffering fromWolman
disease) leads to an infantile-onset phenotype, and affected indi-
viduals usually die within the first month of life. Individuals with
residual LAL activity (patients suffering from CE storage disease)
show amilder phenotype (similar to that of LAL knockout mice),
characterized by CE deposition in visceral tissues, hepatomegaly,
and premature death in adulthood.
Despite the severe defect in CE and TGmetabolism of LAL-
deficient mice and humans, no defect in vitamin Ametabolism
has been reported. In fact, humans suffering from CE storage
disease orWolman disease show normal plasma retinol (ROH)
levels (7). Because intestinal chylomicrons transport TGs, CEs,
and also REs, one would expect that a defect in the lysosomal
system would not only compromise cholesterol and fatty acid
but also vitamin A metabolism.
In this study, we investigated whether REs per se are a sub-
strate for LAL. We found that murine LAL (mLAL) hydrolyzes
REs. Furthermore, pharmacological inhibition of LAL in the
human hepatocyte cell line HepG2 led to an accumulation of
REs in endosomal/lysosomal-enriched fractions, suggesting
that LAL is limiting for the clearance of endocytosed REs.
Unexpectedly, LAL-deficient mice showed decreased RE con-
tent in the liver but increased RE accumulation in the duodenum
and jejunum. Furthermore, upon RE gavage, LAL-deficient mice
exhibited reduced post-prandial RE levels in the circulation, indi-
cating that LAL is required for efficient availability of nutritional
vitamin A. Despite compromised vitamin A availability, LAL-de-
ficient mice exhibited elevated circulating ROH levels, arguing
against a vitamin A deficiency of these mice.
Experimental Procedures
Materials—Essentially fatty acid-free BSA was obtained
from Sigma-Aldrich (St. Louis, MO). 1,2-diheptadecanoyl-sn-
glycero-3-phosphatidylcholine, 1,2-dinonadecanoyl-sn-glycero-
3-phosphatidylcholine, and retinyl acetate were obtained from
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Larodan Fine Chemicals AB (Stockholm, Sweden) and Sigma-
Aldrich and used as internal standards. Retinyl palmitate (RP)
and cholesteryl oleate were purchased from Sigma-Aldrich.
Lalistat 2 was a kind gift fromDr. Paul Helquist (Department of
Chemistry and Biochemistry, University of Notre Dame, Notre
Dame, IN).
Animals—LAL knockout mice were generated as described
previously (4, 5). LAL knockout mice originated from a mixed
129Sv and CF-1 background and were backcrossed onto
C57Bl/6 mice for 10 generations. Mice were obtained from a
heterozygous breeding stock. Littermates were genotyped by
PCR method of the WT and targeted allele as described previ-
ously (5). WT and LAL-deficient mice were maintained on a
regular light-dark cycle (12 h light, 12 h dark) and kept in a clean
environmentwith ad libitum access to food (Altromin 1324, 4%
fat and 19% protein, 15,000 IU vitaminA/kg (as retinyl acetate),
Altromin Spezialfutter GmbH & Co. KG, Lage, Germany) and
water. Age-matched, 3-, 6.5-, and 8-month-oldmale and female
mice were used for all experiments. Mice were sacrificed by
cervical dislocation. All experiments were approved by the Fed-
eralMinistry of Science, Research, and Economy and local ethic
committees andwere in accordancewith theCouncil of Europe
Conventions.
cDNA Cloning of Recombinant His-tagged Proteins—
Poly(A)RNA was isolated from murine liver using the Oligo-
tex mRNA mini kit from Qiagen GmbH (Hilden, Germany).
Liver mRNA was transcribed into first-strand cDNA using the
SuperScript reverse transcriptase protocol (Invitrogen). Sec-
ond-strand cDNA was obtained by addition of Escherichia coli
DNA ligase buffer, E. coli DNA polymerase, E. coli DNA ligase
(all chemicals from New England Biolabs, Inc., Beverly, MA),
and deoxyribonucleotide triphosphates (Carl Roth GmbH and
Co. KG, Karlsruhe, Germany) to the mixture and subsequent
incubation at 16 °C for 3 h. Thereafter, T4 DNA polymerase
(New England Biolabs, Frankfurt am Main, Germany) was
added and further incubated for 20 min to give blunt-end
cDNA. The coding sequences were amplified by PCR from liver
cDNA using Phusion DNA polymerase (New England Bio-
labs). Cloning of mHSL into the mammalian expression vector
pcDNA4/HisMax C (Invitrogen) has been described previously
(8). The mLAL coding sequence was subcloned into the
pcDNA4/HisMax expression vector by overlap extension PCR
to obtain a C-terminal His-tagged fusion protein instead of the
N-terminal His tag of the vector. In brief, the upstream part of
the vector backbone without the His tag and the mLAL coding
sequence were PCR-amplified from the pcDNA4/HisMax C
plasmid containing the mLAL coding sequence. Overlapping
regions and the 3 end-located His tag were introduced by
primers. The newly synthesized PCR fragment and the expres-
sion plasmid pcDNA4/HisMaxCwere digestedwith SacI/XhoI
and ligated. The following primers were used: SP163fw (SacI),
5GCCGAGCTCTAATACGACTCACTATAGGGAGAC
3; SP163/LALrv, 5 GAA CAC CAG GCC CTG GAG TTG
CAT GGT TTC GGA GGC CGT CCG G 3; SP163/LALfw, 5
CCGGACGGCCTCCGAAACCATGCAACTCCAGGGC
CTGGTGTTC 3; and LALrv (XhoI), 5CTCGAGTCAATG
ATG ATG ATG ATG ATG CTG GTA TTT CTT CAT TAG
ACT GAT 3. A control pcDNA4/HisMax vector encoding
-galactosidase (LacZ) was provided by the manufacturer
(Invitrogen).
Expression of Recombinant Proteins and Preparation of Cell
Lysates—Monkey embryonic kidney cells (COS-7, ATCC,
CRL-1651TM) were cultivated in DMEM (Gibco, Invitrogen)
containing 10% fetal calf serum (Sigma-Aldrich) and antibiotics
at 37 °C in humidified air (89–91% saturation) and 5% CO2.
Cells were seeded in 10-cm dishes at a density of 900,000 cells/
dish. The following day, cells were transfected with plasmid
DNAencoding the respectiveHis-tagged recombinant proteins
or LacZ as a control using Metafectene (Biontex, Munich,
Germany) as a transfection reagent. Cells were harvested 2 days
after transfection using a cell scraper. Cells were lysed on ice in
solution A (0.25 M sucrose, 1 mM EDTA, 1 mM DTT, 20 g/ml
leupeptine, 2 g/ml antipain, and 1 g/ml pepstatin (pH 7.0))
by sonication (Virsonic 475, Virtis, Gardiner, NJ). Nuclei and
unbroken cells were removed by centrifugation at 1000 g and
4 °C for 5 min, and lysates were stored at 20 °C until further
use. Expression ofHis-tagged proteinswas assessed byWestern
blotting.
Measurement of in Vitro RE Hydrolase Activity—For assess-
ment of RE hydrolase activity of recombinant proteins, 100 l
of COS-7 cell lysates (100 g of cell protein) containing over-
expressed recombinant proteins and 100 l of substrate were
incubated at 37 °C for 60 min. The reaction was terminated by
addition of 100l ofmethanol containing 1.5M retinyl acetate
as internal standard and 1ml of hexane. Then the samples were
vigorously vortexed and centrifuged at 5000  g for 5 min at
4 °C. The upper hexane phase (800 l) was collected and dried
under nitrogen. Samples were dissolved in 200 l of chloro-
form/methanol (2/1, v/v) and analyzed by HPLC fluorescence
detection (FD) (see “Preparation of Tissue Homogenates and
Quantification of Neutral Lipids by HPLC FD”). Blank incuba-
tion was performed with 100 l of solution A under identical
conditions and used for background correction. The RE sub-
strate contained 600M retinyl palmitate andwas emulsified by
sonication (Virsonic 475, Virtis) with 300Mphosphatidylcho-
line/phosphatidylinositol (PC/PI, 3/1, M/M) in 100 mM potas-
sium phosphate buffer (pH 7.4) or 100 mM sodium acetate
buffer (pH 4.5), respectively. In some cases, substrates also con-
tained increasing concentrations of BMP (0–500 M).
For the measurement of liver acid RE hydrolase activity, per-
fused liver sections of ad libitum-fedmice, 3month of age, were
homogenized in solution A using anUltraTurrax (IKA, Janke &
Kunkel, Germany) and adjusted to a protein concentration of 2
mg/ml. Then 75 l of the prepared lysates (150 g of protein)
was delipidated, and proteins were precipitated by addition of
600 l of ice-cold acetone. Thereafter, precipitated proteins
were pelleted by centrifugation at 20,000 g at 4 °C for 30min.
Pelleted proteins were dried under a stream of nitrogen gas and
dissolved in 100 l of solution A. For quantification of RE
hydrolase activity, 100l of substrate was added and incubated
for 60min at 37 °C. Blank incubations were performedwith 100
l of solution A under identical conditions and 100l of delipi-
dated liver proteinswith sodiumacetate buffer (pH4.5)without
substrate to correct for residual endogenous ROH release. The
substrate contained 600 M retinyl palmitate and was emulsi-
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fied (as above) in 100 mM sodium acetate buffer (pH 4.5) con-
taining 300 M PC/PI (3/1, M/M) and 300 M BMP.
Measurement of inVitroCE andTGHydrolase Activity—The
TG hydrolase activity assay was performed as described previ-
ously (8) with somemodifications. In brief, 100l of COS-7 cell
lysates (30 g of cell protein) was incubated with 100 l of
substrate for 60 min at 37 °C. Blank incubation was performed
with 100 l of solution A under identical conditions and used
for background correction. Reactions were terminated by addi-
tion of 3.25 ml of methanol/chloroform/n-heptane (10/9/7,
v/v/v) and 1 ml 0.1 M potassium carbonate (pH 10.5). After
vigorous mixing, phase separation was achieved by centrifuga-
tion at 1000  g for 10 min. The radioactivity in 200 l of the
upper aqueous phase was determined by liquid scintillation
counting. The TG substrate contained 1.67 mM triolein and
1.25Ci [3H]triolein (per reaction) andwas emulsifiedwith 300
M PC/PI (3/1, M/M) and 300 M BMP in 100 mM potassium
phosphate buffer (pH 7.4) or 100mM sodium acetate buffer (pH
4.5), respectively.
The CE hydrolase activity assay was performed as described
above for the TG hydrolase activity assay. The CE substrate
contained 1mM cholesteryl oleate and 1.25Ci [3H]cholesteryl
oleate (per reaction) and was emulsified with 90MPC/PI (3/1,
M/M) and 90 M BMP in 100 mM potassium phosphate buffer
(pH7.4) or 100mM sodiumacetate buffer (pH4.5), respectively.
Preparation of RE-enriched Lipoproteins—Blood (200 ml)
was collected from a 29-year-old healthy male volunteer, and
EDTA (5 mM) plasma was prepared. Isolation of TG-rich lipo-
proteins was performed according to a standard protocol. In
brief, plasma was adjusted to a density of d 1.21 using potas-
sium bromide and overlaid with a discontinuous salt gradient
(sodium chloride) with densities of d  1.063, d  1.019, and
d 1.006. Samples were centrifuged for 24 h at 40,000 rpm and
4 °C using a Beckman Optima L-90K centrifuge and a SW41
rotor (Beckman Instruments Inc., Palo Alto, CA). After centrif-
ugation, TG-rich lipoproteins mostly consisting of chylomi-
crons and chylomicron remnantswere collected from the top of
the tube and stored at 20 °C for further use. For RE enrich-
ment, 300l of isolated lipoproteinswasmixedwith 40mol of
retinyl palmitate (Sigma-Aldrich) and brought to a total volume
of 2 ml using 10 mM phosphate-buffered saline. Then the mix-
ture was sonicated three times for 30 s with an amplitude of 1
(Virsonic 475, Virtis).
Cultivation of HepG2 Cells and Loading with Human TG-
rich Lipoproteins—HepG2 cells (ATCC, HB-8065TM) were
seeded in Greiner CELLSTAR 6-well cell culture plates
(Sigma-Aldrich) and incubated with DMEM (Gibco, Invitro-
gen), supplemented with 10% fetal calf serum and antibiotics,
under standard cell culture conditions. To inhibit LAL activity,
cellswere incubatedwith 10MLAL inhibitor Lalistat 2 for 72 h
as described previously (11). As a control, cells were incubated
with DMSO. Thereafter, RE-enriched lipoproteins were added
to the incubationmedium to give a final concentration of 10M
RE, and cells were further incubated for 6 h. Cells were washed
twice with Dulbecco’s phosphate-buffered saline and harvested
using a cell scraper, and intracellular retinoid content was ana-
lyzed by HPLC FD as described below.
Isolation of LAMP1/RAB7-rich Fractions—HepG2 cells were
harvested using a cell scraper anddisrupted in bufferA contain-
ing 30% iodixanol (OptiPrepTM, Axis-Shield PoC AS, Kjelsås-
veien, Norway) using a standard Dounce homogenizer. Dis-
rupted cells were transferred to a centrifugation tube and
overlaid with a discontinuous iodixanol gradient (prepared in
solution A) with densities of 20%, 15%, 10%, and 0% iodixanol.
Samples were centrifuged for 2 h at 40,000 rpm and 4 °C using a
Beckman Optima L-90K centrifuge and an SW41 rotor (Beck-
man Instruments Inc.). Bands were collected from the top of
each density interphase (F1, 0–10%; F2, 10–15%; F3, 15–20%)
and analyzed byWestern blotting analysis using ras-associated
protein 7 (Rab7)/lysosomal-associated membrane protein 1
(LAMP1) and protein disulfide isomerase as marker proteins
for endosomes/lysosomes and the endoplasmic reticulum,
respectively.
Preparation of Tissue Homogenates and Quantification of
Neutral Lipids by HPLC FD—Various tissues (100–300 g of
protein) of ad libitum-fed LAL knockout mice and WT litter-
mates were homogenized in solution A using an UltraTurrax
(IKA, Janke & Kunkel). Lipids were Folch-extracted. Briefly,
lipids were extracted twice with chloroform/methanol (2/1,
v/v) containing 1% acetic acid and 500 nM butylated hydroxyl
toluene. Lipid extracts were dried under a stream of nitrogen
and stored at 20 °C. Prior to analysis, dried lipids were dis-
solved in chloroform/methanol (2/1, v/v). TG, PC, free choles-
terol, and CE were separated on a Betasil diol column (100
4.6 mm, 5 m, Thermo Fisher Scientific, Waltham, MA) using
a ternary gradient solvent system and detected by an HPLC
evaporative light scattering detector (16). The HPLC evapora-
tive light scattering detector consisted of a precooled sample
manager (at 4 °C), pump, injector, and column oven (at 40 °C),
all of the 1100 series (Agilent, Santa Clara, CA), and were cou-
pled to a Sedex 85 evaporative light scattering detector (Sedere,
Alfortville, France). Data were analyzed using Chemstation
software (B 04.01, Agilent). Neutral lipid standards were pre-
pared as 1mg/ml stock solutions in chloroform/methanol (2/1,
v/v). Calibration curves were measured from 2.7–350 g/ml.
For retinoid analyses, tissue homogenates were mixed with
an equal amount of methanol containing 1.5 M all-trans reti-
nyl acetate (Sigma-Aldrich) as internal standard. Retinoids
were extracted twice using hexane, as described previously (16).
Organic phases were combined and dried under a stream of
nitrogen and dissolved in chloroform/methanol (2/1, v/v). Ret-
inoids were separated on a YMC-Pro C18 (150  4.6 mm, S-5
m, 12 nm, YMC Europe GmbH, Dinslaken, Germany) using a
gradient solvent system (flow, 1 ml/min; gradient, 1–5 min
100% methanol, 5–14 min 60%/40% methanol/toluene, and
14–18 min 100% methanol) and detected at excitation 325
nm/emission 450 nm. The HPLC consisted of a Waters e2695
separation module, including a column oven (at 25 °C) and a
Waters 2475 fluorescence detector (Waters Corp., Milford,
MA). Data were analyzed using Empower 3 chromatography
data software (Waters Corp.).
Measurement of Plasma ROH and Retinol Binding Protein 4
(RBP4) levels—Blood of ad libitum-fed 8-month-old female
mice was collected, and EDTA plasmawas prepared. For deter-
mination of ROH levels, 40 l of plasma was mixed with 100 l
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ofmethanol containing retinyl acetate (1.5M) as internal stan-
dard, extracted into hexane, and analyzed by HPLC FD (as
above). Plasma RBP4 levels were assessed byWestern blotting.
Administration of Oral RE Gavage and Measurements of
Post-prandial Plasma Retinoid Levels—Female mice, 8 months
of age, wereweighed and received gavage of 300 IU of vitaminA
equivalents (retinyl palmitate in olive oil) per gram of body-
weight using a standard gavage needle. Before and 2 h after
gavage, blood sampleswere collected from the vena facialis, and
EDTA plasma was prepared. For retinoid measurements, 40 l
of plasma was extracted into hexane and analyzed using HPLC
FD (as above).
Analysis of mRNA Expression by Quantitative Real-time
PCR—Total RNA of livers was extracted and reverse-tran-
scribed into cDNA. Quantitative real-time PCR for lecithin:
retinol acyltransferase (LRAT)was performed as described pre-
viously (8). Target gene expression was calculated by the Ct
method using the ribosomal gene 36B4 as a housekeeping gene.
The following primer pairs for detection of LRAT and 36B4
mRNA were used, respectively: LRAT-fw, 5 CCG TCC CTA
TGA AAT CAG CTC 3; LRAT-rev, 5 ATG GGC GAC ACG
GTT TTC C 3; 36B4-fw, 5 GCT TCA TTG TGG GAG CAG
ACA 3; and 36B4-rev, 5 CAT GGT GTT CTT GCC CAT
CAG 3.
Western Blotting Analysis—Proteins of cell extracts, tissue
homogenates, and murine plasma (1/40 dilution) were sepa-
rated by 10% SDS-PAGE and blotted onto polyvinylidene fluo-
ride membranes (Carl Roth GmbH, Karlsruhe, Germany). The
following primary antibodies were used: N-terminal His6 tag
(27-4710-01, Amersham Biosciences, Buckinghamshire, UK),
C-terminal His6 tag (102-PA80, Reliatech, Wolfenbüttel, Ger-
many), and RBP4 (sc-25850, Santa Cruz Biotechnology Inc.,
Dallas, TX) as well as protein disulfide isomerase, LAMP1, and
RAB7 from Cell Signaling Technology (35019, C54H11, and
2094S, respectively, Cambridge, UK). After binding of the sec-
ondary anti-mouse or anti-rabbit horseradish peroxidase-la-
beled antibody, signals were visualized by ECL detection (ECL
Plus/Prime, GE Healthcare). For densitometric analysis, inten-
sities of RBP4 bands were normalized to the corresponding
intensities of the protein stain on the membrane using ImageJ
software (freely available at http://imagej.nih.gov/ij/).
Statistical Analysis—Data are mean  S.D. Statistically sig-
nificant differences were determined by Student’s unpaired t
test (two-tailed). Group differences were considered statisti-
cally significant for p  0.05 (*), p  0.01 (**), and p  0.001
(***).
Results
Lysosomal Acid Lipase Hydrolyzes REs—To determine
whether LAL exhibits hydrolytic activity against REs as sub-
strate, we expressed recombinant mLAL or LacZ (control) in
COS-7 cells. Fig. 1A depicts Western blotting analyses of
recombinant proteins. Incubation of mLAL containing lysates
with RP as substrate at (pH 4.5) led to 1.9-fold increased hydro-
lytic activity compared with control lysates (expressing LacZ)
(Fig. 1B). Because LAL is known to be activated by anionic
phospholipids such as BMP (9), we added increasing concen-
trations of BMP to the substrate. Addition of BMP led to a
dose-dependent increase of RE hydrolase activity of mLAL-
containing lysates, resulting in 	7-fold higher activity at 500
M BMP compared with control lysates (Fig. 1C). To validate
theREhydrolase activity ofmLAL,we performed activity assays
with increasing incubation times and amounts of lysates. As
expected, we observed that, under our assay conditions, mLAL
hydrolyzed RP (in the presence of 300 M BMP) in a time- (Fig.
1D) and dose-dependent (Fig. 1E) manner.
Next we compared the RE hydrolase activity of lysates con-
taining mLAL with lysates containing murine hormone-sensi-
tive lipase (mHSL), a known RE hydrolase (10). Because the
enzymes are active at different pHvalues, we performed activity
assays at acidic and neutral pH. We found that lysates contain-
ing mLAL or mHSL showed	9- and 13-fold increased hydro-
lytic activities against RP as substrate at pH 4.5 or 7.5, respec-
tively (Fig. 2A). As expected, no activity was observed formLAL
at pH 7.5 andmHSL at pH 4.5. Furthermore, mLAL andmHSL
exhibited hydrolytic activities against cholesteryl oleate and tri-
olein as substrates. (Fig. 2, B andC). Together, the results of the
in vitro activity assays demonstrate that mLAL hydrolyzes REs
and that this activity is strongly stimulated in the presence of
BMP.
LAL Is Required for Lysosomal RE Clearance—To investigate
whether LAL plays a role in intracellular RE metabolism, we
used the human hepatocyte cell line HepG2 and the LAL-spe-
cific inhibitor Lalistat 2 (11). We reasoned that inhibition of
LAL may impair the lysosomal clearance of REs and, thus, that
cells may show increased RE accumulation.We incubated cells
with human TG-rich lipoproteins (artificially enriched with
RP) in the absence (DMSO control) or presence of Lalistat 2.
Analysis of cellular retinoid content revealed that cells incu-
bated with Lalistat 2 exhibited increased RP content (2.5-fold),
whereas ROH levels were similar to that of control cells (Fig.
3A). To determine whether RE accumulated in the endosomes/
lysosomes, we enriched these fractions from cells incubated
with Lalistat 2 or DMSO (control) by density gradient centrif-
ugation. Endosomal/lysosomal fractions were identified as
LAMP1/RAB7-positive fractions by Western blotting (Fig. 3B,
inset). Retinoid analyses revealed that the LAMP1/RAB7-en-
riched fraction F1 showed a trend toward increased Res,
whereas fraction F2 showed an	3-fold increasedRE content in
cells treated with Lalistat 2 compared with control cells
(DMSO) (Fig. 3B). In summary, these results suggest that LAL is
required for efficient lysosomal clearance of REs.
LAL Is the Major Acid RE Hydrolase in Murine Liver—To
assess to which extent LAL contributes to acid RE hydrolase
activity in tissues, we precipitated and delipidated proteins of
liver homogenates fromWTand LAL-deficientmice using ace-
tone. Then proteinswere reconstituted in aqueous solution and
incubated with RP as substrate. To assess LAL-dependent
activity, we also added Lalistat 2 to the incubation mixture.We
found that liver protein preparations of LAL-deficient mice
exhibited 85% reduced acid RE hydrolase activity compared
with liver preparations ofWTmice (Fig. 4). Addition of Lalistat
2 to the assay mixtures completely inhibited acid RE hydrolase
activity in liver preparations ofWTmice, whereas no effect was
observable in liver preparations of LAL-deficient mice (Fig. 4).
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These results clearly indicate that LAL is responsible for the
majority of acid RE hydrolase activity in the liver.
LAL-deficient Mice Exhibit Decreased RE Content in the
Liver—To get first insights into the physiological role of LAL in
RE turnover, we determined ROH and RE content in livers of
3-month-old WT and LAL-deficient mice. Against expecta-
tions, we found that livers of LAL-deficient mice exhibit	70%
decreased RE content compared with that of WT littermates,
irrespective of being normalized to milligram of protein of tis-
sue homogenate (Fig. 5, left half) or to gram of tissue weight
(Fig. 5, right half). Decreased retinoid content in livers of LAL-
deficient micemay be caused by decreased deposition of REs in
the liver because of impaired vitamin A supply.
LAL-deficient Mice Accumulate REs in the Duodenum and
Jejunum—The lipid phenotype of LAL-deficient mice is known
to progresswith age (4, 12). Becausewe speculated that thismay
also be the case for disturbances in vitamin A homeostasis, we
measured neutral lipid (including RE) and phospholipid con-
tents in various tissues of 6.5-month-old LAL-deficient mice
and WT littermates. The contents of the main phospholipid
class, PC, were comparable between WT and LAL-deficient
mice in all investigated tissues (Fig. 6). More importantly, and
in accordance with previous reports (4, 5, 12), CE content was
increased manyfold (up to 50-fold) in all investigated tissues of
LAL-deficient mice (Fig. 6, A–E). In contrast, free cholesterol
concentration was virtually unchanged (Fig. 6, A–E). TG and
FIGURE 1.mLAL exhibits RE hydrolase activity, which is stimulated by BMP. COS-7 cells were transfected with pcDNA4/HisMax plasmids encodingmLAL
and -galactosidase (LacZ) as a control. After 48 h, cells were collected, and lysates (1000  g supernatant) were prepared. prot, protein. A, expression of
His-tagged proteins was verified byWestern blotting using-His antibody. B, lysates were incubatedwith RP emulsifiedwith PC/PI in sodium acetate (pH 4.5).
Lipids were extracted into hexane, and ROH content was quantified by HPLC. C, as in B, but increasing concentrations of BMP were added to the substrate. D
and E, lysateswere incubated for various times as indicated (D), or various amounts of lysateswere incubated for 1 hwith substrates as in A but containing 300
M BMP (E). Then the ROH content was determined by HPLC FD, and the rates of hydrolysis were calculated. Data are mean
 S.D. of triplicate determination
and are representative of three independent determinations. Statistically significant differences were determined in comparison with control LacZ by
Student’s unpaired t test (two-tailed). *, p 0.05.
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RE contents were significantly increased in the duodenum and
jejunum, whereas a trend toward increased TG and RE content
was observed in the ileum (Fig. 6,A–C). IncreasedRE content in
the duodenum of LAL-deficient mice was accompanied by
decreased ROH levels (Fig. 6A). In the lung of LAL-deficient
mice, CE content was increased whereas that of REs was
decreased. All other lipid classes in the lung were comparable
between both genotypes (Fig. 6D). In accordance with a previ-
ous report (4), we observed an enlargedmesenteric lymph node
in LAL-deficientmice that contained	0.05 and	0.6 nmol/mg
protein ROH and RP, respectively. Notably, the spleen of LAL-
deficient mice contained largely increased RE content (93
 36
pmol/mg of protein versus 0.17 
 0.15 pmol/mg of protein in
LAL-deficient versusWTmice, respectively). Interestingly, and
similar to what was already observed in 3-month-old LAL-de-
ficient mice, 6.5-month-old LAL-deficient mice also exhibited
reduced ROH and RE content in the liver (Fig. 6E). Because
livers of LAL-deficient mice exhibited unchanged LRAT
mRNA expression (Fig. 6F), decreased hepatic RE content was
apparently not a consequence of a down-regulation of LRAT
expression. Thus, decreased RE content in the liver and lung of
LAL-deficient mice, which was accompanied by an accumula-
tion of REs in the duodenum and jejunum, rather suggests that
the nutritional supply with vitamin A in these mice might be
compromised.
LAL-deficient Mice Exhibit Elevated Circulating ROH:RBP4
but Decreased Post-prandial RE Levels—To investigate
whether accumulation of RE in the duodenum and jejunum
affects circulating vitamin A availability, we measured ROH
concentrations in the plasma of ad libitum-fed mice. Interest-
ingly, we found that circulating ROH levels of LAL-deficient
mice were 2.5-fold higher compared with those of WT mice
(Fig. 7A). To examine whether increased plasma ROH levels
were accompanied by increased levels of its specific transport
protein, RBP4, we performed Western blotting analyses using
an antibody specific against RBP4 (Fig. 7B). Loading equal
amounts of protein, we found more intense bands in plasma
samples of LAL-deficientmice at amolecular weight close to 25
kDa compared with that of control mice. An overlay of the
Western blotting signal with the protein stain of themembrane
showed that the -RBP4 band located right below the intense
protein band at 25 kDa, suggesting that the -RBP4 signal was
apparently due to a specific interactionwith RBP4 protein (	23
kDa). Densitometric quantitation revealed a 3-fold increase in
the RBP4 signal of the Western blot, which is in line with
increased ROH levels in the plasma of LAL-deficient mice.
To investigate whether LAL deficiency affects the nutritional
availability of vitamin A, we performed gavage with an RP:olive
oil bolus and measured post-prandial circulating retinoid lev-
els. Interestingly, after 2 h of RP gavage (T2), LAL-deficient
FIGURE 2.mLAL hydrolyzes RE, CE, and TG substrates at comparable rates. A–C, lysates were incubated with either retinyl palmitate (A), [3H]cholesteryl
oleate (B), or [3H]triolein (C) as substrates in sodium acetate buffer (pH 4.5) or potassiumphosphate buffer (pH 7.5) containing 300MBMP. Then the release of
ROH (A) or 3H fatty acids (FA, B and C) was determined by HPLC FD or scintillation counting, respectively. Rates were normalized to milligram of protein. Data
aremean
 S.D. of triplicate determination and are representative of three independent determinations. Statistically significant differences were determined
in comparison with control LacZ by Student’s unpaired t test (two-tailed). **, p 0.01; ***, p 0.001.
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mice exhibited virtually unchanged plasma ROH levels,
whereas those of WT mice increased by 2.1-fold (Fig. 7C).
Before RP gavage, plasma RP was not detectable in both geno-
types. 2 h after RP gavage, LAL-deficient mice exhibited lower
plasma RP and retinyl stearate (RS) concentration, which in
total corresponded to 70% lower plasma RE content compared
with that ofWTmice (Fig. 7D). Together, the observations that,
upon RP gavage, the plasma ROH content of LAL-deficient
mice did not increase and that their plasma RE content was
markedly reduced demonstrate that LAL is required for effi-
cient nutritional availability of vitamin A. However, LAL is not
limiting for circulating ROH:RBP4 levels, and, if absent, it does
not provoke vitamin A deficiency.
Discussion
This study was prompted by the following observations:
endocytosed chylomicronREs are predominantly cleared in the
early/late endosome andnot in lysosomes (13, 14); twodifferent
enzymes are thought to be responsible for acid RE and CE
hydrolase activity (15); and LAL-deficient mice accumulate
TGs and CEs in various tissues, but RE levels have not been
reported. Because it is conceivable that LAL might be involved
in RE metabolism, we examined whether mLAL exhibits RE
hydrolase activity, the LAL specific inhibitor Lalistat 2 affects
cellular RE levels, and LAL-deficient mice exhibit any changes
in retinoid levels.
In this study, we show that LAL is the major acid RE hydro-
lase. This is evident from the complete inhibition of acid RE
hydrolase activity in liver lysates upon addition of the LAL
inhibitor Lalistat 2 (11), the largely reduced acid RE hydrolase
activity in liver lysates of LAL-deficient mice, the accumulation
of REs in endosomal/lysosomal-enriched fractions in the
human hepatocyte-like HepG2 cells when incubated with Lal-
istat 2, and the increased RE accumulation in the duodenum
and jejunum of LAL-deficient mice. Together, these findings
indicate that LAL is the major acid RE hydrolase, required for
efficient clearance of endocytosed REs and that, when absent
(or inhibited), it cannot be compensated by other enzymes.
FIGURE 3. Inhibition of LAL leads to accumulation of REs in LAMP1/RAB7-
enriched fractions of HepG2 cells.HepG2 cells were incubatedwith DMEM
containing 10 M Lalistat 2 or a solvent control (DMSO) for 72 h. Then the
media were replaced with media containing artificially RP-enriched human
TG-rich lipoproteins (final concentration, 10 M RP) and 10 M Lalistat 2 or
DMSO. After 6 h of incubation, cell lysates were prepared, and endosomal/
lysosomal fractionswere isolated by density ultracentrifugation. Lipids of cell
lysates (A) and endosomal/lysosomal fractions (B, F1 and F2) were extracted
into hexane, and retinoids (ROH and RP) were analyzed by HPLC FD. Retinoid
levels were normalized to milligram of protein. Data are mean
 S.D. of trip-
licate determinations and representative of three independent experiments.
Statistically significant differences were determined between treatment
groups by Student’s unpaired t test (two-tailed). ***, p  0.001. B, inset,
enriched fractions (F1–F3) were analyzed by Western blotting using LAMP1/
RAB7 and protein disulfide isomerase (PDI) as endosomal/lysosomal and
endoplasmic reticulummarker proteins, respectively.
FIGURE 4. LAL is responsible for acid RE hydrolase activity in the liver.
Livers of 6.5-month-old, ad libitum-fed LAL KO mice and WT littermates
were excised, and tissue homogenates were prepared. Proteins of liver
homogenates were precipitated and delipidated with acetone. Then pro-
teins were dissolved in solution A, incubated with RP, and emulsified with
PC/PI as substrate in sodium acetate buffer (pH 4.5) containing 300 M
BMP and in the absence (DMSO) or presence of 10 M Lalistat 2 for 60 min.
Then lipids of reaction mixtures were extracted, and the ROH content was
determined by HPLC FD. Rates of ROH release were normalized to milli-
gram of protein. Data (n 3) are mean
 S.D. of triplicate determinations
and are representative of two independent experiments. Statistically sig-
nificant differences were determined between groups (DMSO and Lalistat
2 and as indicated by the line) by Student’s unpaired t test (two-tailed). ***,
p  0.001.
FIGURE 5. LAL-deficient mice exhibit reduced RE levels in the liver. Livers
of 3-month-old, ad libitum-fed LAL KOmice andWT littermates were excised,
and tissue homogenates were prepared. Lipids of homogenates were
extracted into hexane, and RP content was quantified by HPLC FD. RP con-
tentswerenormalized tomilligramofproteinofhomogenates and togramof
wet tissueweight and expressed as nanomoles of RE permilligram of protein
(left graph) or micrograms of RE per gram of tissue (right graph), respectively.
Data are presented as mean 
 S.D. (n  4 for each genotype). Statistically
significant differences were determined between genotypes by Student’s
unpaired t test (two-tailed). *, p 0.05; **, p 0.01.
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Studies in the 1980s and 1990s characterized the acid hydro-
lytic activity in the liver and found activities against chylomi-
cron-contained REs, CEs, and TGs, whereas rates for TG hy-
drolysis were found to be highest (15). Furthermore, increasing
concentrations of CEs were not found to compete for acid RE
hydrolysis. Acid CE but not acid RE hydrolase activity of liver
lysates was sensitive to micromolar concentrations of typical
ionic halides (e.g. CaCl2) (15). These reports led to the conclu-
sion that two distinct enzymes exist for the hydrolysis of CEs
and REs in the liver. This view was further bolstered by studies
of Blomhoff et al. (14) and Harrison et al. (13). The authors
investigated the clearance of RE chylomicrons by injecting
3H-labeled RE containing chylomicrons into rats. They found
that 3H radioactivity co-migrated time-dependently with the
early endosomal fraction as well as the endoplasmic reticulum
but to a much lesser extent or not at all with late endosomal/
lysosomal fractions in hepatocytes (13, 14). The authors con-
cluded that endocytosed REs are transferred from the endo-
somes directly to the endoplasmic reticulum, thereby bypassing
lysosomes and thus not requiring acid RE hydrolase activity.
Similarly, whenmurine J774macrophages were incubated with
3H-labeled chylomicron REs, the radioactivity was found pre-
dominantly in early endosomes, to a much lesser extend in late
endosomes/lysosomes, andwas time-dependently converted to
[3H]retinol. These findings indicated that endocytosed REs are
already hydrolyzed in early endosomes (17) and are barely
transferred to lysosomes, and thus do not require acid hydroly-
sis in lysosomes (18). However, and in clear contrast to previous
reports, the results of this study show that LAL-deficient mice
exhibit increased RE accumulation in the duodenum and jeju-
num, indicating that the clearance of REs also requires LAL
activity. The observation that purified rabbit liver LAL hydro-
FIGURE 6. LAL-deficientmice accumulate RE in the intestine. Small intestine (A, duodenum; B, jejunum; C, ileum), lung (D), and liver (E and F) of 6.5-month-
old, ad libitum-fed LAL KO mice and WT littermates were excised, tissue homogenates were prepared (A–E), and liver mRNA was isolated (F). Lipids of
homogenates were extracted. CEs, TGs, free cholesterol (FC), and PCs were quantified by HPLC evaporative light scattering detector. For analysis of retinoid
content, lipids of homogenates were extracted into hexane, and ROH and RE (RP  RS) were quantified by HPLC FD. Lipid contents were normalized to
milligram of protein of homogenates. F, LRAT mRNA expression in livers was determined by quantitative real-time PCR and expressed as Ct using the
ribosomal gene 36B4 as a housekeeping gene. Data are presented as mean 
 S.D. (n  4–6 for each genotype). Statistically significant differences were
determined between genotypes by Student’s unpaired t test (two-tailed). *, p 0.05; **, p 0.01; ***, p 0.001.
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lyzes TGs and CEs at comparable rates (2) confirms our find-
ings employing mLAL containing lysates. In addition, we show
in in vitro activity assays that LAL also hydrolyzes RE at a rate
similar to TGs and CEs, suggesting that LAL does not exhibit a
strong preference for any of the neutral lipid ester substrates.
Our study confirms previous observations that LAL-defi-
cient mice exhibit largely increased CE content in multiple tis-
sues (e.g. 42.5-fold in livers of 8-months old LAL-deficientmice
(4)). In comparison, we found that RE contents were signifi-
cantly increased in the duodenum and jejunum but not in liver
and lung, for example. In addition, the degree of RE accumula-
tion was also much more moderate compared with that of CEs
(e.g. 27-fold increased CE versus 2-fold increased RE content in
duodenum of 6.5-month-old mice). This difference in the
degree of CE versus RE accumulation in tissues of LAL-defi-
cientmice is unlikely to reflect differences in the substrate pref-
erence of LALbecausewe found comparable rates in the hydro-
lysis of CE andRE. It ismore feasible that REs are largely cleared
in the circulation and early/late endosomes and that thus clear-
ance of RE depends much less on the activity of LAL.
The observation that LAL-deficient mice exhibit increased
RE levels in the duodenum (	2-fold) and jejunum (	7-fold)
but not in the liver is, to a certain degree, unexpected. It is
known that neutral lipid esters (including REs) are only taken
up in the intestine after their complete hydrolysis involving
transport proteins (19, 20). Thus, non-hydrolyzable retinyl
ether is not taken up from the intestine (21), indicating that
lipid esters are not endocytosed. Furthermore, Du et al. (4)
FIGURE 7. LAL-deficient mice exhibit increased circulating ROH but decreased post-prandial RE contents. A, blood of 8-month-old, ad libitum-fed, age-
and gender-matched LAL-deficient mice (KO) andWT littermates was collected, and EDTA plasma was prepared. Lipids were extracted into hexane, and ROH
content was quantified by HPLC FD. B, plasma proteins were separated by SDS-PAGE and immunoblotted using anti-RBP4 antibody (-RBP4). Proteins on the
membrane were stained with Coomassie Blue and overlaid with the Western blotting signal. For densitometric analyses, intensities of -RBP4 bands were
normalized to the intensities of the corresponding Coomassie protein stains of themembrane using ImageJ software. C andD, mice as in A received a gavage
of 300 IU of vitamin A equivalents RP in olive oil/grambodyweight. Before (T0) and 2 h after (T2) vitamin A gavage, bloodwas collected, and EDTA plasmawas
prepared. Lipids of plasma were extracted into hexane. ROH (C, for time T0 and T2) and RE (D, RP RS, for time T2) were determined by HPLC FD. Data are
expressed as mean 
 S.D. (n  4–6 for each genotype) and are representative of two independent experiments. Statistically significant differences were
determined between genotypes by Student’s unpaired t test (two-tailed). *, p 0.05.
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reported that, in LAL-deficient mice, neutral lipids accumulate
in proliferatingmacrophages in the lamina propria of intestinal
villi. This observation suggests that increased RE content in the
intestine of LAL-deficient mice might not derive from REs
trapped in lysosomes of enterocytes but in macrophages. Con-
sequently, these REs originate rather from the basolateral side
of the intestine, the blood stream, or the lymph and not from
the intestinal lumen. In addition, it has been reported that the
genetic ablation of sterol O-acyltransferase 2 reduces CE accu-
mulation in the intestine of LAL-deficient mice (	50%) (22).
This finding would be in line with the idea that neutral lipid
esters, which accumulate in the intestine of LAL-deficient
mice, derive from intracellular acyltransferase activity, are then
cleared in lysosomes (e.g. hydrolysis of cytosolic lipid droplets
via autophagy and requiring LAL (23)) and do not originate
directly from endocytosed neutral lipids. Such an intracellular
esterification process might be also valid for intestinal REs and
may involve LRAT/acyl-CoA:retinol acyltransferase activity.
The observation, however, that LAL-deficient mice exhibited
reduced post-prandial circulating RE levels upon RE gavage
suggests that LAL may also be required for the availability of
nutritional neutral lipid esters absorbed from the luminal side
of the intestine.
This finding that LAL-deficient mice exhibit reduced post-
prandial circulating RE levels (upon RE bolus) might be rather
interpreted as impaired fat absorption. In line, LAL-deficient
mice have been reported to exert	1.5-fold increased fecal neu-
tral sterol excretion (12). In our study, we have attempted to
measure retinoid excretion but were not able to detect any ret-
inoids in the feces of either WT or LAL-deficient mice. To
circumvent issues such as detection limit or instability of reti-
noids during gut transit, amore sophisticated technique such as
the use of radiolabeled retinoids would be required. However,
the fact that, in a recent study, 13%of humanCE storage disease
patients suffer from chronic diarrhea (24) could be also indica-
tive of intestinal malabsorption.
An apparent difference in disturbed CE versus RE homeosta-
sis of LAL-deficient mice is evident from the observation that
CE accumulates in all tissues investigated, whereas RE levels are
decreased by	30% in the lung and liver (note that the total RE
content of livers of LAL-deficientmicewas increased compared
to that of WT mice because the livers of LAL-deficient mice
were 3.6-fold enlarged). Decreased RE content in the lung and
liver might be explained by decreased nutritional availability of
vitamin A, as evident from decreased post-prandial circulating
REs. The observation, however, that CE accumulate many-
fold in the liver and lung of LAL-deficient mice seemingly
disproves this concept. In any case, it is apparent from the
lipid phenotype of the LAL-deficient mouse that LAL is
essential for CE but not for RE homeostasis. The reason for
this discrepancy is unexplained.
In summary, we conclude that LAL is the major acid RE
hydrolase. Deficiency of LAL results in RE accumulation in the
intestine (duodenum and jejunum) and a reduced post-pran-
dial circulating RE level, indicative of impaired nutritional
availability of REs. Thus, LAL is required for functional vitamin
A homeostasis but, when absent, does not provoke vitamin A
deficiency.
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